Kramer Levin Launches Public Alternative Funds Blog
Electronic Discovery Update: Spring 2013
Dr. Achkar’s practice focuses on development and management of patent portfolios in the biotechnology, pharmaceutical and chemical industries. He has substantial experience in matters involving business, science and law and his practice focuses on three main areas:
Dr. Achkar has represented biotechnology, pharmaceutical and chemical corporations as well as academic institutions in patent prosecution and intellectual property licensing. He advises his clients on how to create and shape intellectual property portfolios to protect valuable assets. He has developed commercially significant patent portfolios in the fields of biologics, small molecule drugs, gene therapy, diagnostics, vaccines, treatment methods, pharmaceutical compounds and formulations.
In addition, Dr. Achkar has significant experience in performing IP due diligence, patentability assessments, freedom-to-operate analyses, invalidity and non-infringement opinions and competitive landscape analyses to a number of clients of varying sizes including, biotech and pharmaceutical start-up companies, universities and research institutions.
Dr. Achkar draws on his vast scientific research experience which includes a Postdoctoral Fellowship at the Department of Pharmacology, Cornell University Medical College from 1991-1995 where he received two grants from the Cancer Research Foundation of America. He is the author of several articles in peer-reviewed scientific journals in the areas of molecular biology, biochemistry, pharmacology, enzymology, nuclear receptors, retinoids, and analytical biochemistry.